Oncofetal protein IMP3: a novel molecular marker that predicts metastasis of papillary and chromophobe renal cell carcinomas
Lohse, Christine M.
Chu, Peigou G.
Woda, Bruce A.
Rock, Kenneth L.
Kwon, Eugene D.
UMass Chan AffiliationsDepartment of Pathology
Carcinoma, Renal Cell
Tumor Markers, Biological
Medicine and Health Sciences
MetadataShow full item record
AbstractBACKGROUND: Whether an oncofetal protein, IMP3, can serve as a prognostic biomarker to predict metastasis for patients with localized papillary and chromophobe subtypes of renal cell carcinomas (RCCs) was investigated. METHODS: The expression of IMP3 in 334 patients with primary papillary and chromophobe RCC from multiple medical centers was evaluated by immunohistochemistry. The 317 patients with localized papillary and chromophobe RCCs were further evaluated for outcome analyses. RESULTS: IMP3 was significantly increased in a subset of localized papillary and chromophobe RCCs that subsequently metastasized. Patients with localized IMP3-positive tumors (n=33; 10%) were over 10 times more likely to metastasize (risk ratio [RR], 11.38; 95% confidence interval [CI], 5.40-23.96; PCONCLUSIONS: IMP3 is an independent prognostic biomarker that can be used to identify a subgroup of patients with localized papillary and chromophobe RCC who are at high risk for developing distant metastasis.
Cancer. 2008 Jun 15;112(12):2676-82. Link to article on publisher's site
Permanent Link to this Itemhttp://hdl.handle.net/20.500.14038/39143